Sequential antibiotic therapy for cost containment in the hospital setting: why not?
Antibiotic cost represents a significant part of hospital budgets all over the world. Restriction policies, however and other similar programmes intervening in antimicrobial prescribing have not always been successful in lowering antibiotic expenditure. Timely switch or sequential therapy from initial intravenous to subsequent equivalent oral treatment has been implemented in many institutions for the same purpose. Using strict criteria for optimum patient selection, switch therapy has been proven both effective as antimicrobial treatment and cost saving. As healthcare resources remain lower than needed, cost-saving policies become very desirable. Thus, switch therapy is expected to be more widely used, since it is a cost containing policy which does not compromise treatment outcome.
Lelekis
M
M
Special Infections Unit, The General Hospital of Athens "G. Gennimatas", Greece.
Gould
I M
IM
D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000191:economics*; D003363:Cost Control; D017721:Hospital Costs; D006801:Humans; D017053:Infection Control / Q000191:economics*; D007262:Infusions, Intravenous; D006113:United Kingdom; D014481:United States
D000900:Anti-Bacterial Agents